Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
17.53
+0.37 (2.16%)
Dec 23, 2024, 4:00 PM EST - Market closed
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $2.31 billion as of December 23, 2024. Its market cap has increased by 256.00% in one year.
Market Cap
2.31B
Enterprise Value
1.88B
1-Year Change
256.00%
Ranking
Category
Stock Price
$17.53
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $2.31B, an increase of 32.19%. That is a compound annual growth rate of 8.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 2.31B | 197.41% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addus HomeCare | 2.36B |
| NewAmsterdam Pharma Company | 2.36B |
| Beam Therapeutics | 2.31B |
| Azenta | 2.30B |
| Ardent Health Partners | 2.29B |
| Iovance Biotherapeutics | 2.25B |
| IDEAYA Biosciences | 2.21B |
| Ligand Pharmaceuticals | 2.17B |